118 related articles for article (PubMed ID: 35524041)
21. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
22. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
23. Probing the antioxidant activity of Δ
Hacke ACM; Lima D; de Costa F; Deshmukh K; Li N; Chow AM; Marques JA; Pereira RP; Kerman K
Analyst; 2019 Aug; 144(16):4952-4961. PubMed ID: 31318364
[TBL] [Abstract][Full Text] [Related]
24. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
Hiltunen AJ; Järbe TU
Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
[TBL] [Abstract][Full Text] [Related]
25. CBD, a precursor of THC in e-cigarettes.
Czégény Z; Nagy G; Babinszki B; Bajtel Á; Sebestyén Z; Kiss T; Csupor-Löffler B; Tóth B; Csupor D
Sci Rep; 2021 Apr; 11(1):8951. PubMed ID: 33903673
[TBL] [Abstract][Full Text] [Related]
26. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.
Englund A; Morrison PD; Nottage J; Hague D; Kane F; Bonaccorso S; Stone JM; Reichenberg A; Brenneisen R; Holt D; Feilding A; Walker L; Murray RM; Kapur S
J Psychopharmacol; 2013 Jan; 27(1):19-27. PubMed ID: 23042808
[TBL] [Abstract][Full Text] [Related]
27. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
28. Synthetic Strategies for Rare Cannabinoids Derived from
Nguyen GN; Jordan EN; Kayser O
J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
[TBL] [Abstract][Full Text] [Related]
29. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
31. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
[TBL] [Abstract][Full Text] [Related]
32. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
33. Origin of Δ
Citti C; Russo F; Linciano P; Strallhofer SS; Tolomeo F; Forni F; Vandelli MA; Gigli G; Cannazza G
Cannabis Cannabinoid Res; 2021; 6(1):28-39. PubMed ID: 33614950
[No Abstract] [Full Text] [Related]
34. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV
Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793
[TBL] [Abstract][Full Text] [Related]
35. Orally administered cannabidiol does not produce false-positive tests for Δ
McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
[TBL] [Abstract][Full Text] [Related]
36. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
37. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
[TBL] [Abstract][Full Text] [Related]
38. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
Dalterio S; Steger R; Mayfield D; Bartke A
Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
[TBL] [Abstract][Full Text] [Related]
39. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
[TBL] [Abstract][Full Text] [Related]
40. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]